Skip to content
Disclosery

MIC Capital Management UK LLP

Follow

13F filer, CIK 1889830, LONDON, United Kingdom

MIC Capital Management UK LLP reported $509,293,008 across 13 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 97.72% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-25-005259

Period
2025-06-30
Reported value
$509M
Holdings
13
Top 10 weight
97.72%
New
1
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
HAYWadded+550,994$7.6M
LYELnew+87,028$769K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SRADexited-660,000-$14.3M
LYELL IMMUNOPHARMA INCexited-1,740,569-$936K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0001085146-25-005259, largest first. % of portfolio is the value over $509,293,008, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
HAYWHAYWARD HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,764,660 shares; 2024Q4: 9,997,545 shares; 2025Q1: 9,997,545 shares; 2025Q2: 10,548,539 shares 10,548,539$146M28.58%+550,994Timeline
MTSRMETSERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,539,540 shares; 2025Q2: 4,539,540 shares 4,539,540$129M25.36%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,451,758 shares; 2024Q4: 9,644,033 shares; 2025Q1: 9,644,032 shares; 2025Q2: 9,644,032 shares 9,644,032$48.8M9.58%0Timeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,412,946 shares; 2024Q4: 1,412,946 shares; 2025Q1: 1,412,946 shares; 2025Q2: 1,412,946 shares 1,412,946$42.3M8.31%0Timeline
QSRRESTAURANT BRANDS INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 386,203 shares; 2024Q4: 386,203 shares; 2025Q1: 386,203 shares; 2025Q2: 386,203 shares 386,203$25.6M5.03%0Timeline
GRABGRAB HOLDINGS LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,000,000 shares; 2024Q4: 5,000,000 shares; 2025Q1: 5,000,000 shares; 2025Q2: 5,000,000 shares 5,000,000$25.1M4.94%0Timeline
METAMETA PLATFORMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 33,300 shares; 2024Q4: 33,300 shares; 2025Q1: 33,300 shares; 2025Q2: 33,300 shares 33,300$24.6M4.83%0Timeline
MNDYMONDAY COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 66,000 shares; 2024Q4: 66,000 shares; 2025Q1: 66,000 shares; 2025Q2: 66,000 shares 66,000$20.8M4.08%0Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 508,569 shares; 2024Q4: 508,569 shares; 2025Q1: 508,569 shares; 2025Q2: 508,569 shares 508,569$18.7M3.67%0Timeline
BABAALIBABA GROUP HLDG LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 150,000 shares; 2024Q4: 150,000 shares; 2025Q1: 150,000 shares; 2025Q2: 150,000 shares 150,000$17M3.34%0Timeline
ACHRARCHER AVIATION INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 700,000 shares; 2024Q4: 700,000 shares; 2025Q1: 700,000 shares; 2025Q2: 700,000 shares 700,000$7.59M1.49%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,460,700 shares; 2024Q4: 4,460,700 shares; 2025Q1: 4,460,700 shares; 2025Q2: 4,460,700 shares 4,460,700$3.27M0.64%0Timeline
LYELLYELL IMMUNOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 87,028 shares 87,028$769K0.15%newTimeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SRADSPORTRADAR GROUP AG660,000$14.3Mshares
LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INC1,740,569$936Kshares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-25-005259 base2025-08-14acceptance time not in the bulk data set